Follow
Basilio Colligris Ph.D
Basilio Colligris Ph.D
Ocupharm Diagnostics SL-Universidad Complutense de Madrid
Verified email at ucm.es - Homepage
Title
Cited by
Cited by
Year
Contact lenses: promising devices for ocular drug delivery
A Guzman-Aranguez, B Colligris, J Pintor
Journal of ocular pharmacology and therapeutics 29 (2), 189-199, 2013
1452013
Ocular manifestations of Alzheimer’s and other neurodegenerative diseases: the prospect of the eye as a tool for the early diagnosis of Alzheimer’s disease
P Colligris, MJ Perez de Lara, B Colligris, J Pintor
Journal of ophthalmology 2018, 2018
722018
Recent developments on dry eye disease treatment compounds
B Colligris, H Awad Alkozi, J Pintor
Saudi Journal of Ophthalmology, 2013
652013
The role and therapeutic potential of melatonin in age-related ocular diseases
PJ Crooke A, Huete-Toral F, Colligris B
Journal Pineal Research, 2017
612017
Update in glaucoma medicinal chemistry: emerging evidence for the importance of melatonin analogues
A Crooke, B Colligris, J Pintor
Current medicinal chemistry 19 (21), 3508-3522, 2012
392012
An update on dry eye disease molecular treatment: advances in drug pipelines
B Colligris, A Crooke, F Huete-Toral, J Pintor
Expert opinion on pharmacotherapy 15 (10), 1371-1390, 2014
352014
Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential
A Crooke, F Huete-Toral, A Martínez-Águila, B Colligris, J Pintor
Expert Opinion on Drug Discovery 7 (10), 989-1001, 2012
272012
Recent patents and developments in glaucoma biomarkers
B Colligris, A Crooke, X Gasull, J Escribano, R Herrero-Vanrell, ...
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 6 (3), 224-234, 2012
112012
Potential role of Rho-associated protein kinase inhibitors for glaucoma treatment
B Colligris, A Crooke, F Huete, J Pintor
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 6 (2), 89-98, 2012
92012
Therapeutic inhibitors for the treatment of dry eye syndrome
CG Rodríguez-Pomar Candela, Pintor Jesus, Colligris Basilio
Expert Opinion in Pharmacotherapy, 2017
82017
Dry eye disease compounds currently under evaluation in clinical trials
B Colligris, J Pintor Just
Ene 16, 48, 2017
42017
Improving 3D mucin visualization by a new device to make impression cytology comparing normal and muco-deficient subjects
B Colligris, A Martin-Gil, B Fonseca, G Carracedo, J Pintor, ...
Investigative Ophthalmology & Visual Science 55 (13), 4874-4874, 2014
22014
Recent patents on Achondroplasia: latest research development
B Colligris, F Huete, A I Guzman-Aranguez, J Pintor
Recent Patents on Regenerative Medicine 3 (3), 264-277, 2013
22013
Preparation and use of an extract of Artemia salina to treat the ocular surface
JJP JUST, MJP DE LARA, FH TORAL, B COLLIGRIS, JGC RODRÍGUEZ
US Patent 10,933,100, 2021
12021
Affordable and Effective Optokinetic Response Methods to Assess Visual Acuity and Contrast Sensitivity in Larval to Juvenile Zebrafish
BNK Alicia Gómez Sánchez, Yolanda Álvarez, Basilio Colligris
Open Research Europe, doi.org/10.1101/2021.04.26.441419, 2021
2021
In Vitro and In Vivo correlation between diadenosine tetraphosphate and osmolarity in Sjögren Syndrome patients.
PJ Colligris B, Carracedo G, Perez de Lara MJ, Guzman Aranguez AI
Investigative Ophthalmology & Visual Science, 2017
2017
An update on dry eye disease molecular treatment: Advances in drug pipelines
B Colligris, A Crooke, F Huete Toral, J Pintor
Ene 12, 56, 2017
2017
Preparación y uso de un extracto de Artemia Salina para tratar la superficie ocular
PJ Carracedo G, Colligris B, Huete Toral F, Perez de Lara MJ
ES Patent P201,600,607, 2016
2016
Estudio del mercado de futuros medicamentos y biomarcadores oculares, basado en el análisis de datos de la propiedad intelectual y de ensayos clínicos
B Colligirs
Universidad Complutense de Madrid, 2016
2016
Fármacos de la enfermedad de ojo seco actualmente en evaluación en ensayos clínicos
B Colligris, J Pintor
An. R. Acad. Farm, 151-178, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–20